Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines.
Delphi method
consensus
guidelines
post-transplant malignancy
skin cancer screening
solid organ transplant recipients
Journal
Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
22
02
2019
revised:
25
03
2019
accepted:
02
09
2019
pubmed:
11
9
2019
medline:
28
7
2020
entrez:
11
9
2019
Statut:
ppublish
Résumé
Skin cancer is the most common malignancy affecting solid organ transplant recipients (SOTR), and SOTR experience increased skin cancer-associated morbidity and mortality. There are no formal multidisciplinary guidelines for skin cancer screening after transplant, and current practices are widely variable. We conducted three rounds of Delphi method surveys with a panel of 84 U.S. dermatologists and transplant physicians to establish skin cancer screening recommendations for SOTR. The transplant team should risk stratify SOTR for screening, and dermatologists should perform skin cancer screening by full-body skin examination. SOTR with a history of skin cancer should continue regular follow-up with dermatology for skin cancer surveillance. High-risk transplant patients include thoracic organ recipients, SOTR age 50 and above, and male SOTR. High-risk Caucasian patients should be screened within 2 years after transplant, all Caucasian, Asian, Hispanic, and high-risk African American patients should be screened within 5 years after transplant. No consensus was reached regarding screening for low-risk African American SOTR. We propose a standardized approach to skin cancer screening in SOTR based on multidisciplinary expert consensus. These guidelines prioritize and emphasize the need for screening for SOTR at greatest risk for skin cancer.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1268-1276Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 Steunstichting ESOT.
Références
Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1; quiz 18-20.
Garrett GL, Blanc PD, Boscardin J, et al. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol 2017; 153: 296.
2016 Annual Report [Internet]. United Network for Organ Sharing, Organ Procurement and Transplantation Network; 2017. Available from: http://optn.transplant.hrsa.gov/latestData/rptData.asp
Garrett GL, Lowenstein SE, Singer JP, He SY, Arron ST. Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013. J Am Acad Dermatol 2016; 75: 106.
Acuna SA, Huang JW, Scott AL, et al. Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant 2017; 17: 103.
Stasko T, Brown MD, Carucci JA, et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30: 642.
Cowen EW, Billingsley EM. Awareness of skin cancer by kidney transplant patients. J Am Acad Dermatol 1999; 40: 697.
Thurot-Guillou C, Templier I, Janbon B, Pinel N, Beani J-C, Leccia M-T. [Dermatologic follow-up and evaluation of skin tumours in renal transplant patients]. Ann Dermatol Venereol 2007; 134: 39.
Horn J, Lock-Andersen J, Rasmussen K, Jemec GBE. [Screening for skin cancer in organ transplant recipients in Denmark]. Ugeskr Laeg 2005; 167: 2762.
Chan A-W, Fung K, Austin PC, et al. Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: population-based cohort study. Am J Transplant 2019; 19: 522.
Lloyd A, Klintmalm G, Qin H, Menter A. Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations. Clin Transplant 2015; 29: 110.
Lowenstein SE, Garrett G, Toland AE, et al. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature. Br J Dermatol 2017; 177: 1202.
Dalkey N, Helmer O. An experimental application of the DELPHI method to the use of experts. Manage Sci 1963; 9: 458.
Brown BB. Delphi Process: A Methodology Used for the Elicitation of Opinions of Experts. Santa Monica, CA: Rand Corp, 1968.
Sackman H. Delphi Assessment: Expert Opinion, Forecasting, and Group Process. Santa Monica, CA: Rand Corp, 1974.
Yee J, Kim DH, Rosen MP, et al. ACR appropriateness criteria colorectal cancer screening. J Am Coll Radiol 2014; 11: 543.
Mainiero MB, Lourenco A, Mahoney MC, et al. ACR appropriateness criteria breast cancer screening. J Am Coll Radiol 2016; 13: R45.
Hendrick RE, Helvie MA. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death. AJR Am J Roentgenol 2012; 198: 723.
Jambusaria-Pahlajani A, Crow LD, Lowenstein S, et al. Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multi-center cohort study. Transplant Int 2019; 000: 000.
Dybbro E, Mihalis E, Hirose R, Arron ST. Validity of patient skin cancer report among organ transplant recipients. Clin Transplant 2012; 26: E132.
Fitzpatrick T. Soleil et peau. J Med Esthet 1975; 2: 33.
Weinstock MA. Assessment of sun sensitivity by questionnaire: validity of items and formulation of a prediction rule. J Clin Epidemiol 1992; 45: 547.
He SY, McCulloch CE, Boscardin WJ, Chren M-M, Linos E, Arron ST. Self-reported pigmentary phenotypes and race are significant but incomplete predictors of Fitzpatrick skin phototype in an ethnically diverse population. J Am Acad Dermatol 2014; 71: 731.
Chung CL, Nadhan KS, Shaver CM, et al. Comparison of posttransplant dermatologic diseases by race. JAMA Dermatol 2017; 153: 552.
US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for skin cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016; 316: 429.
Brouwers MC, Kerkvliet K, Spithoff K, AGREE Next Steps Consortium. The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines. BMJ 2016; 352: i1152.